FES/FER kinase signaling in hematopoietic cells and leukemias

Frontiers in Bioscience

Volumn 17, Issue 3, 2012, Pages 861-875

  Craig, Andrew W B ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

FES FER protein tyrosine kinases; Hematopoiesis; Leukemia; Mast cells; Review; Signal transduction

Indexed keywords

MUS;

EID: 84858843244     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3961     Document Type: Article

References (139)

1. Franchini, G., J. Even, C. J. Sherr & F. Wong-Staal: onc sequences (v-fes) of Snyder-Theilen feline sarcoma virus are derived from noncontiguous regions of a cat cellular gene (c-fes). Nature, 290, 154-7 (1981). (Pubitemid 11149694)
2. Hampe, A., I. Laprevotte, F. Galibert, L. A. Fedele & C. J. Sherr: Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes. Cell, 30, 775-85 (1982).
3. Sherr, C. J., L. A. Fedele, M. Oskarsson, J. Maizel & G. V. Woude: Molecular cloning of Snyder-Theilen feline leukemia and sarcoma viruses: comparative studies of feline sarcoma virus with its natural helper virus and with Moloney murine sarcoma virus. J Virol, 34, 200-12 (1980). (Pubitemid 10149396)
4. Shibuya, M. & H. Hanafusa: Nucleotide sequence of Fujinami sarcoma virus: evolutionary relationship of its transforming gene with transforming genes of other sarcoma viruses. Cell, 30, 787-95 (1982). (Pubitemid 13204664)
5. Shibuya, M., T. Hanafusa, H. Hanafusa & J. R. Stephenson: Homology exists among the transforming sequences of avian and feline sarcoma viruses. Proc Natl Acad Sci USA, 77, 6536-40 (1980). (Pubitemid 11219163)
6. Groffen, J., N. Heisterkamp, M. Shibuya, H. Hanafusa & J. R. Stephenson: Transforming genes of avian (v-fps) and mammalian (v-fes) retroviruses correspond to a common cellular locus. Virology, 125, 480-6 (1983). (Pubitemid 13120124)
7. Letwin, K., S. P. Yee & T. Pawson: Novel proteintyrosine kinase cDNAs related to fps/fes and eph cloned using anti-phosphotyrosine antibody. Oncogene, 3, 621-627 (1988). (Pubitemid 19030371)
8. Pawson, T., K. Letwin, T. Lee, Q. L. Hao, N. Heisterkamp & J. Groffen: The FER gene is evolutionarily conserved and encodes a widely expressed member of the FPS/FES protein-tyrosine kinase family. Mol. Cell. Biol., 9, 5722-5725 (1989). (Pubitemid 20004393)
9. Aspenstrom, P.: A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton. Current Biology, 7, 479- 87 (1997). (Pubitemid 27308971)
10. Greer, P.: Closing in on the biological functions of fps/fes and fer. Nat Rev Mol Cell Biol, 3, 278-89. (2002). (Pubitemid 34619263)
11. Itoh, T., J. Hasegawa, K. Tsujita, Y. Kanaho & T. Takenawa: The tyrosine kinase Fer is a downstream target of the PLD-PA pathway that regulates cell migration. Sci Signal, 2, ra52 (2009).
12. McPherson, V. A., S. Everingham, R. Karisch, J. A. Smith, C. M. Udell, J. Zheng, Z. Jia & A. W. Craig: Contributions of F-BAR and SH2 domains of Fes protein tyrosine kinase for coupling to the FcepsilonRI pathway in mast cells. Mol Cell Biol, 29, 389-401 (2009).
13. Cetkovic, H., I. M. Muller, W. E. Muller & V. Gamulin: Characterization and phylogenetic analysis of a cDNA encoding the Fes/FER related, non-receptor protein-tyrosine kinase in the marine sponge sycon raphanus. Gene, 216, 77-84 (1998). (Pubitemid 28389104)
14. Bahia, D., R. A. Mortara, J. R. Kusel, L. F. Andrade, F. Ludolf, P. R. Kuser, L. Avelar, J. Trolet, C. Dissous, R. J. Pierce & G. Oliveira: Schistosoma mansoni: expression of Fes-like tyrosine kinase SmFes in the tegument and terebratorium suggests its involvement in host penetration. Exp Parasitol, 116, 225-32 (2007). (Pubitemid 46722602)
15. Ludolf, F., D. Bahia, L. F. Andrade, A. Cousin, M. Capron, C. Dissous, R. J. Pierce & G. Oliveira: Molecular analysis of SmFes, a tyrosine kinase of Schistosoma mansoni orthologous to the members of the Fes/Fps/Fer family. Biochem Biophys Res Commun, 360, 163-72 (2007) (Pubitemid 46994710)
16. Katzen, A. L., D. Montarras, J. Jackson, R. F. Paulson, T. Kornberg & J. M. Bishop: A gene related to the proto-oncogene fps/fes is expressed at diverse times during the life cycle of Drosophila melanogaster. Molecular & Cellular Biology, 11, 226-39 (1991). (Pubitemid 21895200)
17. Murray, M. J., C. M. Davidson, N. M. Hayward & A. H. Brand: The Fes/Fer non-receptor tyrosine kinase cooperates with Src42A to regulate dorsal closure in Drosophila. Development, 133, 3063-73 (2006). (Pubitemid 44404330)
18. Paulson, R., J. Jackson, K. Immergluck & J. M. Bishop: The DFer gene of Drosophila melanogaster encodes two membrane-associated proteins that can both transform vertebrate cells. Oncogene, 14, 641-52 (1997). (Pubitemid 27095855)
19. Lim, W. A. & T. Pawson: Phosphotyrosine signaling: evolving a new cellular communication system. Cell, 142, 661-7.
20. Haigh, J., J. McVeigh & P. Greer: The fps/fes tyrosine kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells and is localized in the trans-golgi network. Cell Growth Differ., 7, 931-944 (1996). (Pubitemid 26360733)
21. Keller, P., J. L. Payne, G. Tremml, P. A. Greer, M. Gaboli, P. P. Pandolfi & M. Bessler: FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow. J Exp Med, 194, 581-9 (2001). (Pubitemid 32844769)
22. Shaffer, J. M. & T. E. Smithgall: Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer. Genes Chromosomes Cancer, 48, 272-84 (2009).
23. Delfino, F. J., H. Stevenson & T. E. Smithgall: A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer. J Biol Chem, 281, 8829-35 (2006). (Pubitemid 43847989)
24. Sangrar, W., R. A. Zirgnibl, Y. Gao, W. J. Muller, Z. Jia & P. A. Greer: An identity crisis for fps/fes: oncogene or tumor suppressor? Cancer Res, 65, 3518-22 (2005). (Pubitemid 40616322)
25. Truesdell, P. F., R. A. Zirngibl, S. Francis, W. Sangrar & P. A. Greer: fps/fes knockout mice display a lactation defect and the fps/fes tyrosine kinase is a component of Ecadherin- based adherens junctions in breast epithelial cells during lactation. Exp Cell Res, 315, 2929-40 (2009).
26. Carlson, A., J. M. Berkowitz, D. Browning, D. J. Slamon, J. C. Gasson & K. E. Yates: Expression of c-Fes protein isoforms correlates with differentiation in myeloid leukemias. DNA Cell Biol, 24, 311-6 (2005). (Pubitemid 40656504)
27. Ferrari, S., U. Torelli, L. Selleri, A. Donelli, D. Venturelli, L. Moretti & G. Torelli: Expression of human cfes onc-gene occurs at detectable levels in myeloid but not in lymphoid cell populations. Br. J. Haematol., 59, 21-25 (1985). (Pubitemid 15188815)
28. Jucker, M., A. J. Roebroek, J. Mautner, K. Koch, D. Eick, V. Diehl, W. J. Van De Ven & H. Tesch: Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines. Oncogene, 7, 943-52 (1992).
29. Gerhard, D. S., L. Wagner, E. A. Feingold, C. M. Shenmen, L. H. Grouse, G. Schuler, S. L. Klein, S. Old, R. Rasooly, P. Good, M. Guyer, A. M. Peck, J. G. Derge, D. Lipman, F. S. Collins, W. Jang, S. Sherry, M. Feolo, L. Misquitta, E. Lee, K. Rotmistrovsky, S. F. Greenhut, C. F. Schaefer, K. Buetow, T. I. Bonner, D. Haussler, J. Kent, M. Kiekhaus, T. Furey, M. Brent, C. Prange, K. Schreiber, N. Shapiro, N. K. Bhat, R. F. Hopkins, F. Hsie, T. Driscoll, M. B. Soares, T. L. Casavant, T. E. Scheetz, M. J. Brownstein, T. B. Usdin, S. Toshiyuki, P. Carninci, Y. Piao, D. B. Dudekula, M. S. Ko, K. Kawakami, Y. Suzuki, S. Sugano, C. E. Gruber, M. R. Smith, B. Simmons, T. Moore, R. Waterman, S. L. Johnson, Y. Ruan, C. L. Wei, S. Mathavan, P. H. Gunaratne, J. Wu, A. M. Garcia, S. W. Hulyk, E. Fuh, Y. Yuan, A. Sneed, C. Kowis, A. Hodgson, D. M. Muzny, J. McPherson, R. A. Gibbs, J. Fahey, E. Helton, M. Ketteman, A. Madan, S. Rodrigues, A. Sanchez, M. Whiting, A. Madari, A. C. Young, K. D. Wetherby, S. J. Granite, P. N. Kwong, C. P. Brinkley, R. L. Pearson, G. G. Bouffard, R. W. Blakesly, E. D. Green, M. C. Dickson, A. C. Rodriguez: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res, 14, 2121-7 (2004). (Pubitemid 39440194)
30. Hackenmiller, R. & M. C. Simon: Truncation of c-fes via gene targeting results in embryonic lethality and hyperproliferation of hematopoietic cells. Dev Biol, 245, 255-69 (2002). (Pubitemid 34521600)
31. Fischman, K., J. C. Edman, G. M. Shackleford, J. A. Turner, W. J. Rutter & U. Nir: A murine fer testis-specific transcript (ferT) encodes a truncated Fer protein. Mol. Cell. Biol., 10, 146-153 (1990).
32. Chen, Y. M., N. P. Lee, D. D. Mruk, W. M. Lee & C. Y. Cheng: Fer kinase/FerT and adherens junction dynamics in the testis: an in vitro and in vivo study. Biol Reprod, 69, 656-72 (2003). (Pubitemid 36885973)
33. Keshet, E., A. Itin, K. Fischman & U. Nir: The testisspecific transcript (ferT) of the tyrosine kinase FER is expressed during spermatogenesis in a stage-specific manner. Mol. Cell. Biol., 10, 5021-5025 (1990).
34. Craig, A. W., R. Zirngibl, K. Williams, L. A. Cole & P. A. Greer: Mice devoid of fer protein-tyrosine kinase activity are viable and fertile but display reduced cortactin phosphorylation. Mol Cell Biol, 21, 603-13. (2001). (Pubitemid 32037378)
35. Kierszenbaum, A. L., E. Rivkin & L. L. Tres: Expression of Fer testis (FerT) tyrosine kinase transcript variants and distribution sites of FerT during the development of the acrosome-acroplaxome-manchette complex in rat spermatids. Dev Dyn, 237, 3882-91 (2008).
36. Arregui, C., P. Pathre, J. Lilien & J. Balsamo: The nonreceptor tyrosine kinase fer mediates cross-talk between N- cadherin and beta1-integrins. J. Cell. Biol., 149, 1263- 1274 (2000).
37. Putzke, A. P. & J. H. Rothman: Repression of Wnt signaling by a Fer-type nonreceptor tyrosine kinase. Proc Natl Acad Sci USA, 107, 16154-9 (2010).
38. Aspenstrom, P., A. Fransson & N. Richnau: Pombe Cdc15 homology proteins: regulators of membrane dynamics and the actin cytoskeleton. Trends Biochem Sci, 31, 670-9 (2006). (Pubitemid 44791944)
39. Chitu, V. & E. R. Stanley: Pombe Cdc15 homology (PCH) proteins: coordinators of membrane-cytoskeletal interactions. Trends Cell Biol, 17, 145-56 (2007). (Pubitemid 46341827)
40. Heath, R. J. & R. H. Insall: F-BAR domains: multifunctional regulators of membrane curvature. J Cell Sci, 121, 1951-4 (2008). (Pubitemid 352015191)
41. Suetsugu, S., K. Toyooka & Y. Senju: Subcellular membrane curvature mediated by the BAR domain superfamily proteins. Semin Cell Dev Biol, 21, 340-9 (2010).
42. Tsujita, K., S. Suetsugu, N. Sasaki, M. Furutani, T. Oikawa & T. Takenawa: Coordination between the actin cytoskeleton and membrane deformation by a novel membrane tubulation domain of PCH proteins is involved in endocytosis. J Cell Biol, 172, 269-79 (2006). (Pubitemid 43112973)
43. Henne, W. M., H. M. Kent, M. G. Ford, B. G. Hegde, O. Daumke, P. J. Butler, R. Mittal, R. Langen, P. R. Evans & H. T. McMahon: Structure and analysis of FCHo2 FBAR domain: a dimerizing and membrane recruitment module that effects membrane curvature. Structure, 15, 839-52 (2007). (Pubitemid 47042426)
44. Shimada, A., H. Niwa, K. Tsujita, S. Suetsugu, K. Nitta, K. Hanawa-Suetsugu, R. Akasaka, Y. Nishino, M. Toyama, L. Chen, Z. J. Liu, B. C. Wang, M. Yamamoto, T. Terada, A. Miyazawa, A. Tanaka, S. Sugano, M. Shirouzu, K. Nagayama, T. Takenawa & S. Yokoyama: Curved EFC/F-BAR-domain dimers are joined end to end into a filament for membrane invagination in endocytosis. Cell, 129, 761-72 (2007). (Pubitemid 46813111)
45. Sangrar, W., Y. Gao, M. Scott, P. Truesdell & P. A. Greer: Fer-Mediated Cortactin Phosphorylation Is Associated with Efficient Fibroblast Migration and Is Dependent on Reactive Oxygen Species Generation during Integrin-Mediated Cell Adhesion. Mol Cell Biol, 27, 6140- 52 (2007). (Pubitemid 47326701)
46. Craig, A. & P. Greer: Fer Kinase Is Required For Sustained p38 MAP kinase Activation and Maximal Chemotaxis of Activated Mast Cells. Mol. Cell. Biol., 22, 6363-6374 (2002).
47. Meckling-Gill, K. A., S. P. Yee, J. W. Schrader & T. Pawson: A retrovirus encoding the v-fps protein-tyrosine kinase induces factor-independent growth and tumorigenicity in FDC-P1 cells. Biochimica et Biophysica Acta, 1137, 65-72 (1992).
48. Greer, P. A., K. Meckling-Hansen & T. Pawson: The human c-fps/fes gene product expressed ectopically in rat fibroblasts is nontransforming and has restrained proteintyrosine kinase activity. Mol Cell Biol, 8, 578-87 (1988). (Pubitemid 18044874)
49. Greer, P., J. Haigh, G. Mbamalu, W. Khoo, A. Bernstein & T. Pawson: The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Molecular & Cellular Biology, 14, 6755-63 (1994). (Pubitemid 24299745)
50. Rao, Y., Q. Ma, A. Vahedi-Faridi, A. Sundborger, A. Pechstein, D. Puchkov, L. Luo, O. Shupliakov, W. Saenger & V. Haucke: Molecular basis for SH3 domain regulation of F-BAR-mediated membrane deformation. Proc Natl Acad Sci USA, 107, 8213-8.
51. Maru, Y., K. L. Peters, D. E. Afar, M. Shibuya, O. N. Witte & T. E. Smithgall: Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Molecular & Cellular Biology, 15, 835-42 (1995).
52. Laurent, C. E., F. J. Delfino, H. Y. Cheng & T. E. Smithgall: The human c-Fes tyrosine kinase binds tubulin and microtubules through separate domains and promotes microtubule assembly. Mol Cell Biol, 24, 9351-8 (2004). (Pubitemid 39391673)
53. Lunter, P. C. & G. Wiche: Direct binding of plectin to Fer kinase and negative regulation of its catalytic activity. Biochem Biophys Res Commun, 296, 904-10 (2002).
54. Andra, K., B. Nikolic, M. Stocher, D. Drenckhahn & G. Wiche: Not just scaffolding: plectin regulates actin dynamics in cultured cells. Genes Dev, 12, 3442-51 (1998). (Pubitemid 28520991)
55. Rosato, R., J. M. Veltmaat, J. Groffen & N. Heisterkamp: Involvement of the tyrosine kinase fer in cell adhesion. Mol. Cell. Biol., 18, 5762-5770 (1998). (Pubitemid 28450527)
56. Fan, L., C. Di Ciano-Oliveira, S. A. Weed, A. W. Craig, P. A. Greer, O. D. Rotstein & A. Kapus: Actin depolymerization-induced tyrosine phosphorylation of cortactin: the role of Fer kinase. Biochem J, 380, 581-91 (2004). (Pubitemid 38788130)
57. Cheng, H., J. A. Rogers, N. A. Dunham & T. E. Smithgall: Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains. Mol. Cell. Biol., 19, 8335-8343 (1999). (Pubitemid 30414027)
58. Cheng, H. Y., A. P. Schiavone & T. E. Smithgall: A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells. Mol Cell Biol, 21, 6170-80. (2001). (Pubitemid 34263517)
59. Craig, A. W. B., R. Zirngibl & P. Greer: Disruption of coiled-coil domains in Fer protein-tyrosine kinase abolishes trimerization but not kinase activation. J. Biol. Chem., 274, 19934-19942 (1999).
60. Kim, L. & T. W. Wong: The cytoplasmic tyrosine kinase FER is associated with the catenin-like substrate pp120 and is activated by growth factors. Mol. Cell. Biol., 15, 4553-4561 (1995).
61. Shaffer, J. M., S. Hellwig & T. E. Smithgall: Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells. Biochemistry, 48, 4780-8 (2009).
62. Smithgall, T. E., J. A. Rogers, K. L. Peters, J. Li, S. D. Briggs, J. M. Lionberger, H. Cheng, A. Shibata, B. Scholtz, S. Schreiner & N. Dunham: The c-Fes family of proteinFES/tyrosine kinases. Critical Reviews in Oncogenesis, 9, 43-62 (1998).
63. Oppermann, F. S., F. Gnad, J. V. Olsen, R. Hornberger, Z. Greff, G. Keri, M. Mann & H. Daub: Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics, 8, 1751-64 (2009).
64. Rikova, K., A. Guo, Q. Zeng, A. Possemato, J. Yu, H. Haack, J. Nardone, K. Lee, C. Reeves, Y. Li, Y. Hu, Z. Tan, M. Stokes, L. Sullivan, J. Mitchell, R. Wetzel, J. Macneill, J. M. Ren, J. Yuan, C. E. Bakalarski, J. Villen, J. M. Kornhauser, B. Smith, D. Li, X. Zhou, S. P. Gygi, T. L. Gu, R. D. Polakiewicz, J. Rush & M. J. Comb: Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell, 131, 1190-203 (2007). (Pubitemid 350235027)
65. Filippakopoulos, P., M. Kofler, O. Hantschel, G. D. Gish, F. Grebien, E. Salah, P. Neudecker, L. E. Kay, B. E. Turk, G. Superti-Furga, T. Pawson & S. Knapp: Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell, 134, 793- 803 (2008).
66. Hikri, E., S. Shpungin & U. Nir: Hsp90 and a tyrosine embedded in the Hsp90 recognition loop are required for the Fer tyrosine kinase activity. Cell Signal, 21, 588-96 (2009).
67. Cockcroft, S.: Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci, 58, 1674-87 (2001). (Pubitemid 32996102)
68. Boucrot, E., S. Saffarian, R. Massol, T. Kirchhausen & M. Ehrlich: Role of lipids and actin in the formation of clathrin-coated pits. Exp Cell Res, 312, 4036-48 (2006). (Pubitemid 44828048)
69. Su, W., O. Yeku, S. Olepu, A. Genna, J. S. Park, H. Ren, G. Du, M. H. Gelb, A. J. Morris & M. A. Frohman: 5- Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol Pharmacol, 75, 437-46 (2009).
70. Nishikimi, A., H. Fukuhara, W. Su, T. Hongu, S. Takasuga, H. Mihara, Q. Cao, F. Sanematsu, M. Kanai, H. Hasegawa, Y. Tanaka, M. Shibasaki, Y. Kanaho, T. Sasaki, M. A. Frohman & Y. Fukui: Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis. Science, 324, 384-7 (2009).
71. Li, H., Z. Ren, X. Kang, L. Zhang, X. Li, Y. Wang, T. Xue, Y. Shen & Y. Liu: Identification of tyrosinephosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells. BMC Cancer, 9, 366 (2009).
72. Tong, J., P. Taylor, E. Jovceva, J. R. St-Germain, L. L. Jin, A. Nikolic, X. Gu, Z. H. Li, S. Trudel & M. F. Moran: Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. J Proteome Res, 7, 1067- 77 (2008).
73. Cao, L., K. Yu, C. Banh, V. Nguyen, A. Ritz, B. J. Raphael, Y. Kawakami, T. Kawakami & A. R. Salomon: Quantitative time-resolved phosphoproteomic analysis of mast cell signaling. J Immunol, 179, 5864-76 (2007).
74. Hayun, R., S. Shpungin, H. Malovani, M. Albeck, E. Okun, U. Nir & B. Sredni: Novel involvement of the immunomodulator AS101 in IL-10 signaling, via the tyrosine kinase Fer. Ann N Y Acad Sci, 1095, 240-50 (2007). (Pubitemid 47092456)
75. Smith, J. A., L. A. Samayawardhena & A. W. Craig: Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and beta1 integrin receptors. Cell Signal, 22, 427-36 (2010).
76. Nakatani, H., M. Kobayashi, T. Jin, T. Taguchi, T. Sugimoto, T. Nakano, S. Hamada & K. Araki: STI571 (Glivec) inhibits the interaction between c-KIT and heat shock protein 90 of the gastrointestinal stromal tumor cell line, GIST-T1. Cancer Sci, 96, 116-9 (2005). (Pubitemid 40425387)
77. Fumo, G., C. Akin, D. D. Metcalfe & L. Neckers: 17- Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells. Blood, 103, 1078-84 (2004). (Pubitemid 38129574)
78. Bauer, S., L. K. Yu, G. D. Demetri & J. A. Fletcher: Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor. Cancer Res, 66, 9153-61 (2006). (Pubitemid 44521135)
79. Yu, W., Q. Rao, M. Wang, Z. Tian, D. Lin, X. Liu & J. Wang: The Hsp90 inhibitor 17-allylamide-17- demethoxygeldanamycin induces apoptosis and differentiation of Kasumi-1 harboring the Asn822Lys KIT mutation and down-regulates KIT protein level. Leuk Res, 30, 575-82 (2006). (Pubitemid 43374587)
80. Lionberger, J. M. & T. E. Smithgall: The c-Fes proteintyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl. Cancer Research, 60, 1097-103 (2000). (Pubitemid 30129551)
81. Yu, G., T. E. Smithgall & R. I. Glazer: K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation. J Biol Chem, 264, 10276-81 (1989). (Pubitemid 19159301)
82. Hanazono, Y., S. Chiba, K. Sasaki, H. Mano, A. Miyajima, K. Arai, Y. Yazaki & H. Hirai: c-fps/fes proteintyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. EMBO J., 12, 1641-1646 (1993). (Pubitemid 23112819)
83. Linnekin, D., S. M. Mou, P. Greer, D. L. Longo & D. K. Ferris: Phosphorylation of a Fes-related protein in response to granulocyte- macrophage colony stimulating factor. J Biol Chem, 270, 4950-4 (1995).
84. Kim, J. & R. A. Feldman: Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1. Mol Cell Biol, 22, 1903-18 (2002). (Pubitemid 34175005)
85. Heydemann, A., G. Juang, K. Hennessy, M. S. Parmacek & M. C. Simon: The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor. Molecular & Cellular Biology, 16, 1676-86 (1996). (Pubitemid 26095640)
86. Nelson, K. L., J. A. Rogers, T. L. Bowman, R. Jove & T. E. Smithgall: Activation of STAT3 by the c-Fes proteintyrosine kinase. Journal of Biological Chemistry, 273, 7072-7 (1998). (Pubitemid 28160376)
87. Hegde, S., S. Ni, S. He, D. Yoon, G. S. Feng, S. S. Watowich, R. F. Paulson & P. A. Hankey: Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation. Oncogene, 28, 3349-59 (2009).
88. Hankey, P. A.: Regulation of hematopoietic cell development and function by Stat3. Front Biosci, 14, 5273-90 (2009).
89. Hackenmiller, R., J. Kim, R. A. Feldman & M. C. Simon: Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice. Immunity, 13, 397-407 (2000).
90. Zirngibl, R. A., Y. Senis & P. A. Greer: Enhanced endotoxin sensitivity in fps/fes-null mice with minimal defects in hematopoietic homeostasis. Mol Cell Biol, 22, 2472-86. (2002). (Pubitemid 34262970)
91. Roebroek, A. J., J. A. Schalken, M. J. Bussemakers, H. van Heerikhuizen, C. Onnekink, F. M. Debruyne, H. P. Bloemers & W. J. Van de Ven: Characterization of human c-fes/fps reveals a new transcription unit (fur) in the immediately upstream region of the proto-oncogene. Mol Biol Rep, 11, 117-25 (1986).
92. Molloy, S. S., E. D. Anderson, F. Jean & G. Thomas: Bicycling the furin pathway: from TGN localization to pathogen activation and embryogenesis. Trends Cell Biol, 9, 28-35 (1999). (Pubitemid 29138669)
93. Roebroek, A. J., L. Umans, I. G. Pauli, E. J. Robertson, F. van Leuven, W. J. Van De Ven & D. B. Constam: Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin. Development, 125, 4863-76 (1998). (Pubitemid 29026768)
94. Senis, Y., R. Zirngibl, J. McVeigh, A. Haman, T. Hoang & P. A. Greer: Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis. Mol. Cell. Biol., 19, 7436-7446 (1999). (Pubitemid 29493407)
95. Senis, Y. A., A. W. Craig & P. A. Greer: Fps/Fes and Fer protein-tyrosinekinases play redundant roles in regulating hematopoiesis. Exp Hematol, 31, 673-81 (2003). (Pubitemid 36945379)
96. Parsons, S. A. & P. A. Greer: The Fps/Fes kinase regulates the inflammatory response to endotoxin through down-regulation of TLR4, NF-{kappa}B activation, and TNF-{alpha} secretion in macrophages. J Leukoc Biol (2006).
97. Parsons, S. A., J. D. Mewburn, P. Truesdell & P. A. Greer: The Fps/Fes kinase regulates leucocyte recruitment and extravasation during inflammation. Immunology (2007).
98. McCafferty, D. M., A. W. Craig, Y. A. Senis & P. A. Greer: Absence of Fer protein-tyrosine kinase exacerbates leukocyte recruitment in response to endotoxin. J Immunol, 168, 4930-5 (2002). (Pubitemid 34495954)
99. Aspenstrom, P.: Roles of F-BAR/PCH proteins in the regulation of membrane dynamics and actin reorganization. Int Rev Cell Mol Biol, 272, 1-31 (2009).
100. Cosen-Binker, L. I. & A. Kapus: Cortactin: the gray eminence of the cytoskeleton. Physiology (Bethesda), 21, 352-61 (2006). (Pubitemid 44511763)
101. Galli, S. J., M. Grimbaldeston & M. Tsai: Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol, 8, 478- 86 (2008). (Pubitemid 351733419)
102. Gilfillan, A. M. & J. Rivera: The tyrosine kinase network regulating mast cell activation. Immunol Rev, 228, 149-69 (2009).
103. Sangrar, W., Y. Gao, B. Bates, R. Zirngibl & P. A. Greer: Activated Fps/Fes tyrosine kinase regulates erythroid differentiation and survival. Exp Hematol, 32, 935-45 (2004). (Pubitemid 39410708)
104. Voisset, E., S. Lopez, A. Chaix, M. Vita, C. George, P. Dubreuil & P. De Sepulveda: FES kinase participates in KIT-ligand induced chemotaxis. Biochem Biophys Res Commun, 393, 174-8 (2010).
105. Petti, F., A. Thelemann, J. Kahler, S. McCormack, L. Castaldo, T. Hunt, L. Nuwaysir, L. Zeiske, H. Haack, L. Sullivan, A. Garton & J. D. Haley: Temporal quantitation of mutant Kit tyrosine kinase signaling attenuated by a novel thiophene kinase inhibitor OSI-930. Mol Cancer Ther, 4, 1186-97 (2005). (Pubitemid 41149566)
106. Voisset, E., S. Lopez, P. Dubreuil & P. De Sepulveda: The tyrosine kinase FES is an essential effector of KITD816V proliferation signal. Blood, 110, 2593-9 (2007). (Pubitemid 47523183)
107. Samayawardhena, L. A., J. Hu, P. L. Stein & A. W. Craig: Fyn kinase acts upstream of Shp2 and p38 mitogenactivated protein kinase to promote chemotaxis of mast cells towards stem cell factor. Cell Signal, 18, 1447-1454 (2006). (Pubitemid 43832080)
108. O'Laughlin-Bunner, B., N. Radosevic, M. L. Taylor, Shivakrupa, C. DeBerry, D. D. Metcalfe, M. Zhou, C. Lowell & D. Linnekin: Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells. Blood, 98, 343-50 (2001).
109. Yu, M., J. Luo, W. Yang, Y. Wang, M. Mizuki, Y. Kanakura, P. Besmer, B. G. Neel & H. Gu: The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway. J Biol Chem, 281, 28615-26 (2006). (Pubitemid 44507004)
110. Piao, X., R. Paulson, P. van der Geer, T. Pawson & A. Bernstein: Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA, 93, 14665-9 (1996).
111. Hong, L., V. Munugalavadla & R. Kapur: c-Kitmediated overlapping and unique functional and biochemical outcomes via diverse signaling pathways. Mol Cell Biol, 24, 1401-10 (2004). (Pubitemid 38112199)
112. Ueda, S., M. Mizuki, H. Ikeda, T. Tsujimura, I. Matsumura, K. Nakano, H. Daino, Z. Honda Zi, J. Sonoyama, H. Shibayama, H. Sugahara, T. Machii & Y. Kanakura: Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3- kinase on calcium mobilization and cell migration. Blood, 99, 3342-3349. (2002). (Pubitemid 34525315)
113. Samayawardhena, L. A., R. Kapur & A. W. Craig: Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells. Blood, 109, 3679-86 (2007). (Pubitemid 46641716)
114. Agosti, V., S. Corbacioglu, I. Ehlers, C. Waskow, G. Sommer, G. Berrozpe, H. Kissel, C. M. Tucker, K. Manova, M. A. Moore, H. R. Rodewald & P. Besmer: Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development. J Exp Med, 199, 867-78 (2004). (Pubitemid 38375206)
115. Kimura, Y., N. Jones, M. Kluppel, M. Hirashima, K. Tachibana, J. B. Cohn, J. L. Wrana, T. Pawson & A. Bernstein: Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages. Proc Natl Acad Sci USA, 101, 6015-20 (2004). (Pubitemid 38520520)
116. Brunati, A. M., R. Deana, A. Folda, M. L. Massimino, O. Marin, S. Ledro, L. A. Pinna & A. Donella-Deana: Thrombin-induced tyrosine phosphorylation of HS1 in human platelets is sequentially catalyzed by Syk and Lyn tyrosine kinases and associated with the cellular migration of the protein. J Biol Chem, 280, 21029-35 (2005). (Pubitemid 40805661)
117. Hao, J. J., G. B. Carey & X. Zhan: Syk-mediated tyrosine phosphorylation is required for the association of hematopoietic lineage cell-specific protein 1 with lipid rafts and B cell antigen receptor signalosome complex. J Biol Chem, 279, 33413-20 (2004). (Pubitemid 39062990)
118. Gomez, T. S., S. D. McCarney, E. Carrizosa, C. M. Labno, E. O. Comiskey, J. C. Nolz, P. Zhu, B. D. Freedman, M. R. Clark, D. J. Rawlings, D. D. Billadeau & J. K. Burkhardt: HS1 functions as an essential actinregulatory adaptor protein at the immune synapse. Immunity, 24, 741-52 (2006). (Pubitemid 43867363)
119. Butler, B., D. H. Kastendieck & J. A. Cooper: Differently phosphorylated forms of the cortactin homolog HS1 mediate distinct functions in natural killer cells. Nat Immunol, 9, 887-97 (2008).
120. Scielzo, C., M. T. Bertilaccio, G. Simonetti, A. Dagklis, E. Ten Hacken, C. Fazi, M. Muzio, V. Caiolfa, D. Kitamura, U. Restuccia, A. Bachi, M. Rocchi, M. Ponzoni, P. Ghia & F. Caligaris-Cappio: HS1 has a central role in the trafficking and homing of leukemic B cells. Blood (2010).
121. Kim, M. S., H. S. Kuehn, D. D. Metcalfe & A. M. Gilfillan: Activation and function of the mTORC1 pathway in mast cells. J Immunol, 180, 4586-95 (2008).
122. Munugalavadla, V., E. C. Sims, J. Borneo, R. J. Chan & R. Kapur: Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis. Blood, 110, 1612-20 (2007). (Pubitemid 47443979)
123. Munugalavadla, V., E. C. Sims, R. J. Chan, S. D. Lenz & R. Kapur: Requirement for p85alpha regulatory subunit of class IA PI3K in myeloproliferative disease driven by an activation loop mutant of KIT. Exp Hematol, 36, 301-8 (2008).
124. Udell, C. M., L. A. Samayawardhena, Y. Kawakami, T. Kawakami & A. W. Craig: Fer and Fps/Fes participate in a Lyn-dependent pathway from FcepsilonRI to plateletendothelial cell adhesion molecule 1 to limit mast cell activation. J Biol Chem, 281, 20949-57 (2006). (Pubitemid 44115436)
125. Holowka, D., E. D. Sheets & B. Baird: Interactions between Fc(epsilon)RI and lipid raft components are regulated by the actin cytoskeleton. J Cell Sci, 113 ( Pt 6), 1009-19 (2000). (Pubitemid 30179480)
126. Kovarova, M., P. Tolar, R. Arudchandran, L. Draberova, J. Rivera & P. Draber: Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation. Mol Cell Biol, 21, 8318-28 (2001). (Pubitemid 33108592)
127. Odom, S., G. Gomez, M. Kovarova, Y. Furumoto, J. J. Ryan, H. V. Wright, C. Gonzalez-Espinosa, M. L. Hibbs, K. W. Harder & J. Rivera: Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med, 199, 1491-502 (2004). (Pubitemid 38780404)
128. Wong, M. X., D. Roberts, P. A. Bartley & D. E. Jackson: Absence of platelet endothelial cell adhesion molecule-1 (CD31) leads to increased severity of local and systemic IgE-mediated anaphylaxis and modulation of mast cell activation. J Immunol, 168, 6455-62 (2002). (Pubitemid 34620070)
129. Zhang, L., S. Y. Oh, X. Wu, M. H. Oh, F. Wu, J. T. Schroeder, C. M. Takemoto, T. Zheng & Z. Zhu: SHP-1 deficient mast cells are hyperresponsive to stimulation and critical in initiating allergic inflammation in the lung. J Immunol, 184, 1180-90 (2010).
130. McPherson, V. A., N. Sharma, S. Everingham, J. Smith, H. H. Zhu, G. S. Feng & A. W. Craig: SH2 domaincontaining phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrowderived mast cells. J Immunol, 183, 4940-7 (2009).
131. Huynh, H., N. Bottini, S. Williams, V. Cherepanov, L. Musumeci, K. Saito,
132. Wang, X., H. Huynh, A. Gjorloff-Wingren, E. Monosov, M. Stridsberg, M. Fukuda & T. Mustelin: Enlargement of secretory vesicles by protein tyrosine phosphatase PTP-MEG2 in rat basophilic leukemia mast cells and Jurkat T cells. J Immunol, 168, 4612-9 (2002). (Pubitemid 34441367)
133. Deng, Z., T. Zink, H. Y. Chen, D. Walters, F. T. Liu & G. Y. Liu: Impact of actin rearrangement and degranulation on the membrane structure of primary mast cells: a combined atomic force and laser scanning confocal microscopy investigation. Biophys J, 96, 1629-39 (2009).
134. Nielsen, E. H., K. Braun & T. Johansen: Reorganization of the subplasmalemmal cytoskeleton in association with exocytosis in rat mast cells. Histol Histopathol, 4, 473-7 (1989). (Pubitemid 19259794)
135. Kim, J., Y. Ogata, H. Ali & R. A. Feldman: The Fes tyrosine kinase: a signal transducer that regulates myeloidspecific gene expression through transcriptional activation. Blood Cells Mol Dis, 32, 302-8 (2004). (Pubitemid 38296695)
136. Smith, C. A. & G. Fan: The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms. Hum Pathol, 39, 795-810 (2008). (Pubitemid 351758946)
137. Voisset, E., S. Lopez, A. Chaix, C. Georges, K. Hanssens, T. Prebet, P. Dubreuil & P. De Sepulveda: FES kinases are required for oncogenic FLT3 signaling. Leukemia, 24, 721-8 (2010).
138. Tiedemann, R. E., Y. X. Zhu, J. Schmidt, H. Yin, C. X. Shi, Q. Que, G. Basu, D. Azorsa, L. M. Perkins, E. Braggio, R. Fonseca, P. L. Bergsagel, S. Mousses & A. K. Stewart: Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6. Blood, 115, 1594-604 (2010).
139. Breitkopf, S. B., F. S. Oppermann, G. Keri, M. Grammel & H. Daub: Proteomics Analysis of Cellular Imatinib Targets and their Candidate Downstream Effectors. J Proteome Res (2010).